These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5655488)

  • 21. [Use of tolinase (tolazamide) in diabetes mellitus].
    Genes SG; Grinchenko TS; Lobanovskaia LI
    Vrach Delo; 1969 Apr; 4():40-4. PubMed ID: 5373588
    [No Abstract]   [Full Text] [Related]  

  • 22. [The development of sulfonylurea late resistance].
    Angeli I
    Med Klin; 1970 Feb; 65(7):306-9. PubMed ID: 4996930
    [No Abstract]   [Full Text] [Related]  

  • 23. The use and abuse of oral hypoglycemic agents.
    Sussman KE
    Rocky Mt Med J; 1967 Feb; 64(2):56-9. PubMed ID: 6045352
    [No Abstract]   [Full Text] [Related]  

  • 24. Standards of diabetic control.
    Duncan GG; Duncan TG
    Med Clin North Am; 1966 Sep; 50(5):1371-83. PubMed ID: 5971576
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment with a new antidiabetic: glybenclamide].
    Madsen SN; Persson I
    Ugeskr Laeger; 1970 Jan; 132(4):143-7. PubMed ID: 5442953
    [No Abstract]   [Full Text] [Related]  

  • 26. [Acetohexamide (Ordimel) in the treatment of diabetes mellitus].
    Tjorstad KO
    Tidsskr Nor Laegeforen; 1967 Jul; 87(14):1277-9. PubMed ID: 6046773
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term results with oral hypoglycemic drugs.
    Moss JM; DeLawter DE
    J Am Geriatr Soc; 1973 Feb; 21(2):72-6. PubMed ID: 4688111
    [No Abstract]   [Full Text] [Related]  

  • 28. Tolinase--a new oral antidiabetic drug.
    Med Lett Drugs Ther; 1966 Sep; 8(19):77-8. PubMed ID: 5971398
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulin-independent diabetes mellitus.
    Bricker LA; Mintz DH
    Med Clin North Am; 1971 Mar; 55(2):295-304. PubMed ID: 4926053
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study of oral hypoglycemic agents. VI. Comparative study on acute oral overload using tolbutamide and tolazamide in normal and diabetic subjects. Various aspects of the prolonged use of tolazamide in comparison with other sulfonylureas].
    Pereira VG; Wajchenberg BL; Shnaider J
    Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):133-42. PubMed ID: 5322747
    [No Abstract]   [Full Text] [Related]  

  • 31. [Testing a new antidiabetic (Glibenclamid) in hospitalized and ambulatory diabetics].
    Belser F; Brögli H; Constam G; Zollikofer H
    Schweiz Rundsch Med Prax; 1970 Apr; 59(16):598-601. PubMed ID: 4997187
    [No Abstract]   [Full Text] [Related]  

  • 32. Attempts to delay the progression of chemical diabetes.
    Jimenez JA; Oppermann W; De Lellis RH; Camerini-Dávalos RA
    Adv Metab Disord; 1970; 1():Suppl 1:421+. PubMed ID: 5446909
    [No Abstract]   [Full Text] [Related]  

  • 33. TOLAZAMIDE (TOLANASE) -- A NEW SULPHONYLUREA.
    BECKETT AG; DONOVAN RJ
    Br J Clin Pract; 1965 May; 19():275-9. PubMed ID: 14286139
    [No Abstract]   [Full Text] [Related]  

  • 34. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.
    Tsalikian E; Dunphy TW; Bohannon NV; Lorenzi M; Gerich JE; Forsham PH; Kane JP; Karam JH
    Diabetes; 1977 Apr; 26(4):314-21. PubMed ID: 849812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yet another sulphonylurea for late-onset diabetics.
    S Afr Med J; 1969 Aug; 43(32):973-4. PubMed ID: 5822219
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antidiabetics. 42].
    Jacker HJ
    Pharm Prax; 1969 Dec; 12():270-9. PubMed ID: 4913446
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intravenous tolbutamide test in secondary failure of antidiabetic sulfonamides].
    Canivet J; Jacotot B
    Sem Hop; 1968 Apr; 44(17):1147-51. PubMed ID: 4299418
    [No Abstract]   [Full Text] [Related]  

  • 39. The comparative clinical effectiveness of tolbutamide and acetohexamide.
    Duncan TG; Smith JB; Duncan GG
    Metabolism; 1968 Mar; 17(3):218-25. PubMed ID: 4867884
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].
    Schöffling K; Petzoldt R; Althoff-Zucker C; Beyer J; Retiene K; Böhle E; Kunkel W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1439-45. PubMed ID: 5394468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.